Clinical trial
Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis
NCT04602390
Study timeline
Study start (actual)2020-11-06Date precision: day
Registry last updated2025-05-31
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Multiple Sclerosis (MS)unresolved
Relapsing Remitting Multiple Sclerosisunresolved
Interventions
Sponsors & collaborators
Anokion SAlead sponsor
Mapped research locations
HoustonTexas, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1ClevelandOhio, United States1TampaFlorida, United States1PhoenixArizona, United States1AuroraColorado, United States1New OrleansLouisiana, United States1Kansas CityKansas, United States1TacomaWashington, United States1ColumbiaSouth Carolina, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04602390 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.